Molecular Cancer Q1
Unclaimed
BioMed Central Ltd.
United Kingdom
Molecular Cancer is a journal indexed in SJR in Molecular Medicine and Oncology with an H index of 171. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 3890 €. The scope of the journal is focused on oncology, tumour biology, cancer antigens. It has an SJR impact factor of 8,703 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 8,703.
Molecular Cancer focuses its scope in these topics and keywords: expression, cells, colon, cell, cancer, prostate, methylation, lung, receptor, survival, ...
Type: Journal
Type of Copyright: CC BY + CC0
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -


Price
3890 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
8,703
SJR Impact factor171
H Index210
Total Docs (Last Year)484
Total Docs (3 years)17736
Total Refs17050
Total Cites (3 years)436
Citable Docs (3 years)28.85
Cites/Doc (2 years)84.46
Ref/DocOther journals with similar parameters
Cell Stem Cell Q1
Pharmacological Reviews Q1
Genome Medicine Q1
EMBO Molecular Medicine Q1
Polish Botanical Journa-Plant Fungal and Sistematics Q1
Compare this journals
Comments